VANCOUVER, BRITISH COLUMBIA--(Marketwire - November 14, 2007) - Tekmira Pharmaceuticals Corporation ("Tekmira") (TSX: TKM) reported today in its Third Quarter 2007 operating results that its internal and partnered drug development programs are on track to have as many as eight treatments for cancer and other diseases in human clinical trials by the end of 2008.
